World Solve

Children's mental health needs are often noticed later than physical ones, partly due to stigma and inconsistent screening in schools and pediatric care. Normalizing early mental health checkups remains an unmet goal in most systems.

Rates of some cancers are rising among people under fifty for reasons researchers don't yet fully understand, spanning diet, environment, and other unknown factors. Identifying the cause is a necessary first step toward prevention.

Undiagnosed vision problems in children can quietly affect school performance for years before being caught. Early, affordable screening at scale remains unavailable in many school systems worldwide.

Antibiotics are widely used in livestock farming to prevent disease and promote growth, contributing significantly to antibiotic resistance in humans. Reducing this use without harming farmers' livelihoods remains a persistent unresolved challenge.

Dental problems can affect overall health significantly, yet dental care is often separated from general healthcare systems and priced out of reach for many. Closing this gap remains an overlooked but serious healthcare access issue.

A meaningful share of people who contracted COVID-19 continue experiencing fatigue, brain fog, or other symptoms long after recovery, with no reliably effective treatment yet available. This remains a significant and only partially understood health burden.

Air pollution contributes to respiratory and cardiovascular disease in millions of people living in polluted urban areas, and treatment only addresses symptoms, not exposure. Reducing the exposure itself remains the harder, unresolved half of the problem.

Some slow-growing cancers are unlikely to ever threaten a patient's life, yet current diagnostics often can't tell them apart from dangerous ones. This leads to both overtreatment and, at times, dangerous undertreatment.

Malnutrition during early childhood can cause lifelong developmental harm, and crises like war or drought regularly disrupt food access for vulnerable children. Building more resilient food delivery systems in crisis zones remains urgently unresolved.

Chronic fatigue syndrome leaves patients severely limited in daily function, yet its underlying biological cause remains poorly understood and often dismissed. Without a clear cause, effective treatment remains extremely difficult to develop.

Early detection dramatically improves skin cancer survival rates, but many people lack easy access to dermatology screening. A cheap, widely available detection tool could catch far more cases before they become dangerous.

Tuberculosis remains a major killer in some regions, and drug-resistant strains are becoming harder and more expensive to treat. Slowing this resistance requires both better medicine access and improved treatment adherence support.

Infertility affects a significant share of couples trying to conceive, and treatments like IVF don't work for everyone or every cause. A deeper understanding of underlying causes could open new, more effective treatment paths.

Postpartum depression affects many new parents, often going undiagnosed until it significantly affects their wellbeing and their child's early development. Better early prediction could allow support to begin before symptoms take hold.

Many countries are seeing their elderly populations grow faster than their caregiving systems can support, straining families and healthcare systems alike. A scalable, affordable model for elder care remains an unmet need almost everywhere.

Food allergy rates have been rising for decades, and the exact reasons behind this trend remain only partially understood. Understanding the cause could help prevent, not just manage, this growing health issue.

Because rare diseases affect few patients, there's often little financial incentive for researchers or companies to develop treatments. Thousands of rare conditions remain effectively untreated as a direct result.

Countries with opt-out organ donation systems tend to have far higher donation rates, saving more lives, but implementing this fairly and ethically worldwide remains politically and culturally difficult.

Personalized medicine is improving, but doctors still can't always predict in advance which patients will respond to a given treatment. Solving this could avoid painful trial-and-error treatment periods for patients.

Existing dementia treatments offer only modest, temporary relief from symptoms rather than meaningfully slowing the underlying disease. A real disease-modifying treatment remains one of medicine's most sought-after breakthroughs.